We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Reaction Biology, a drug discovery CRO with offices in Pennsylvania and Germany, and 4HF Biotec GmbH, a bioinformatics firm based in Freiburg, Germany, have announced a new cell-based service offering that combines Reaction Biology's ProLiFiler cell ...